Cargando…

A Novel Platform of MOF for Sonodynamic Therapy Advanced Therapies

Metal–organic frameworks (MOFs) combined with sonodynamic therapy (SDT) have been introduced as a new and efficient treatment method. The critical advantage of SDT is its ability to penetrate deep tissues and concentrate energy on the tumor site to achieve a non-invasive or minimally invasive effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Donghui, Huang, Jiefeng, Jiang, Chenyi, Zhou, Luyi, Zheng, Mingbin, Nezamzadeh-Ejhieh, Alireza, Qi, Na, Lu, Chengyu, Liu, Jianqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458442/
https://www.ncbi.nlm.nih.gov/pubmed/37631285
http://dx.doi.org/10.3390/pharmaceutics15082071
_version_ 1785097166661877760
author Liao, Donghui
Huang, Jiefeng
Jiang, Chenyi
Zhou, Luyi
Zheng, Mingbin
Nezamzadeh-Ejhieh, Alireza
Qi, Na
Lu, Chengyu
Liu, Jianqiang
author_facet Liao, Donghui
Huang, Jiefeng
Jiang, Chenyi
Zhou, Luyi
Zheng, Mingbin
Nezamzadeh-Ejhieh, Alireza
Qi, Na
Lu, Chengyu
Liu, Jianqiang
author_sort Liao, Donghui
collection PubMed
description Metal–organic frameworks (MOFs) combined with sonodynamic therapy (SDT) have been introduced as a new and efficient treatment method. The critical advantage of SDT is its ability to penetrate deep tissues and concentrate energy on the tumor site to achieve a non-invasive or minimally invasive effect. Using a sonosensitizer to generate reactive oxygen species (ROS) under ultrasound is the primary SDT-related method of killing tumor cells. In the presence of a sonosensitizer, SDT exhibits a more lethal effect on tumors. The fast development of micro/nanotechnology has effectively improved the efficiency of SDT, and MOFs have been broadly evaluated in SDT due to their easy synthesis, easy surface functionalization, high porosity, and high biocompatibility. This article reviews the main mechanism of action of sonodynamic therapy in cancer treatment, and also reviews the applications of MOFs in recent years. The application of MOFs in sonodynamic therapy can effectively improve the targeting ability of SDT and the conversion ability of reactive oxygen species, thus improving their killing ability on cancer cells. This provides new ideas for the application of micro/nano particles in SDT and cancer therapy.
format Online
Article
Text
id pubmed-10458442
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104584422023-08-27 A Novel Platform of MOF for Sonodynamic Therapy Advanced Therapies Liao, Donghui Huang, Jiefeng Jiang, Chenyi Zhou, Luyi Zheng, Mingbin Nezamzadeh-Ejhieh, Alireza Qi, Na Lu, Chengyu Liu, Jianqiang Pharmaceutics Review Metal–organic frameworks (MOFs) combined with sonodynamic therapy (SDT) have been introduced as a new and efficient treatment method. The critical advantage of SDT is its ability to penetrate deep tissues and concentrate energy on the tumor site to achieve a non-invasive or minimally invasive effect. Using a sonosensitizer to generate reactive oxygen species (ROS) under ultrasound is the primary SDT-related method of killing tumor cells. In the presence of a sonosensitizer, SDT exhibits a more lethal effect on tumors. The fast development of micro/nanotechnology has effectively improved the efficiency of SDT, and MOFs have been broadly evaluated in SDT due to their easy synthesis, easy surface functionalization, high porosity, and high biocompatibility. This article reviews the main mechanism of action of sonodynamic therapy in cancer treatment, and also reviews the applications of MOFs in recent years. The application of MOFs in sonodynamic therapy can effectively improve the targeting ability of SDT and the conversion ability of reactive oxygen species, thus improving their killing ability on cancer cells. This provides new ideas for the application of micro/nano particles in SDT and cancer therapy. MDPI 2023-08-01 /pmc/articles/PMC10458442/ /pubmed/37631285 http://dx.doi.org/10.3390/pharmaceutics15082071 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Liao, Donghui
Huang, Jiefeng
Jiang, Chenyi
Zhou, Luyi
Zheng, Mingbin
Nezamzadeh-Ejhieh, Alireza
Qi, Na
Lu, Chengyu
Liu, Jianqiang
A Novel Platform of MOF for Sonodynamic Therapy Advanced Therapies
title A Novel Platform of MOF for Sonodynamic Therapy Advanced Therapies
title_full A Novel Platform of MOF for Sonodynamic Therapy Advanced Therapies
title_fullStr A Novel Platform of MOF for Sonodynamic Therapy Advanced Therapies
title_full_unstemmed A Novel Platform of MOF for Sonodynamic Therapy Advanced Therapies
title_short A Novel Platform of MOF for Sonodynamic Therapy Advanced Therapies
title_sort novel platform of mof for sonodynamic therapy advanced therapies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458442/
https://www.ncbi.nlm.nih.gov/pubmed/37631285
http://dx.doi.org/10.3390/pharmaceutics15082071
work_keys_str_mv AT liaodonghui anovelplatformofmofforsonodynamictherapyadvancedtherapies
AT huangjiefeng anovelplatformofmofforsonodynamictherapyadvancedtherapies
AT jiangchenyi anovelplatformofmofforsonodynamictherapyadvancedtherapies
AT zhouluyi anovelplatformofmofforsonodynamictherapyadvancedtherapies
AT zhengmingbin anovelplatformofmofforsonodynamictherapyadvancedtherapies
AT nezamzadehejhiehalireza anovelplatformofmofforsonodynamictherapyadvancedtherapies
AT qina anovelplatformofmofforsonodynamictherapyadvancedtherapies
AT luchengyu anovelplatformofmofforsonodynamictherapyadvancedtherapies
AT liujianqiang anovelplatformofmofforsonodynamictherapyadvancedtherapies
AT liaodonghui novelplatformofmofforsonodynamictherapyadvancedtherapies
AT huangjiefeng novelplatformofmofforsonodynamictherapyadvancedtherapies
AT jiangchenyi novelplatformofmofforsonodynamictherapyadvancedtherapies
AT zhouluyi novelplatformofmofforsonodynamictherapyadvancedtherapies
AT zhengmingbin novelplatformofmofforsonodynamictherapyadvancedtherapies
AT nezamzadehejhiehalireza novelplatformofmofforsonodynamictherapyadvancedtherapies
AT qina novelplatformofmofforsonodynamictherapyadvancedtherapies
AT luchengyu novelplatformofmofforsonodynamictherapyadvancedtherapies
AT liujianqiang novelplatformofmofforsonodynamictherapyadvancedtherapies